Professional Documents
Culture Documents
Wait For Your Cue in Jazz Pharma
Wait For Your Cue in Jazz Pharma
Wait For Your Cue in Jazz Pharma
US EQUITY | HEALTHCARE
Share Comment 0
Stock quotes in this article: JAZZ
Jazz Pharmaceuticals (JAZZ) is starting to look interesting on the buy side at least as long as we limit our risk! Let's
look at the setup, starting with the daily chart.
Jazz Pharmaceuticals (JAZZ)
Daily
Source: Dynamic Trader
View Chart » View in New Window »
I've been stalking two areas of support in this one. The first zone comes in between $127.23 and $131.25, and it
includes the confluence of at least five Fibonacci price relationships within a relatively tight range. The second zone
comes in between $122.41 and $124.03.
The share price is currently above the 200day simple moving average, though it does not have the support of the 50
Follow us on: SUBSCRIBE | LOG IN | ALERTS
day SMA, nor has its fiveday exponential moving average crossed above the 13day EMA. Still, as long as we have
time and price on our side, we can still look at a relatively lowrisk bet against Jazz Pharma's recent low.
Besides the price axis of the market, there had also been a nice confluence of time relationships that came due
between March 27 and April 1 yesterday for a possible low. When I see a cluster of time cycles, it tells me to watch
for a reversal into them and, since Jazz Pharma was trading lower into the beginning of those cycles, I knew the odds
were higher than usual for the possible start of a upside reversal.
Given the recent declines we've seen in some key stocks recently, I prefer to not step in front of the proverbial freight
train. That is, I prefer to see if there are some further indications that it's worth placing a bet.
This is why I wait for a trigger and, in the case of Jazz Pharma, we have already seen the pattern shift to a bullish one
on a 30minute chart. In addition to that, the eightday EMA has crossed above the 34day line, which I like to see
before I'll jump into a trade. At this point, I'm looking at a buy entry on a pullback to the most recent low, which the stock
hit on March 27.
Jazz Pharmaceuticals (JAZZ)
15Minute
Source: Dynamic Trader
View Chart » View in New Window »
On the 15minute chart above, I've identified the pertinent pullback zone. In general, when I look at a pullback after the
stock has put in its initial trigger, I look for an entry zone anywhere between the 50% and 0.786 retracements back to
the recent lows. I'll be watching this area today which, for this stock, means $133.88 to $137.52.
For this stock in particular, I will consider a bullish options strategy, and my maximum risk will be defined below the
$130.61 swing low. The potential upside target is around $189.11. The hurdles on the way up will be at $149.92 and
$159.03.
Since our trades don't always make targets, I like to move to a breakeven stoploss when it makes sense to do so. Let's
see if Jazz can hold up!
Please refer here for more information on trade triggers.
See here for general guidance on Fibonacci trade setups.
Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.
More From Carolyn Boroden
TSLA chart updated
MGM Updated Chart
SQ Chart Updated: Target 1 Met
https://realmoney.thestreet.com/articles/04/02/2014/wait-your-cue-jazz-pharma 1/2
7/6/2018 Wait for Your Cue in Jazz Pharma
At the time of publication, Boroden had no positions in the stocks mentioned.
TAGS: TECHNICAL ANALYSIS | HEALTHCARE
© 19962018 TheStreet, Inc. All rights reserved.
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided
by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.
TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time
period.
FactSet calculates the Market Cap for the basic symbol to include common shares only. Yeartodate mutual fund returns are calculated on a monthly basis by Value Line and posted midmonth.
https://realmoney.thestreet.com/articles/04/02/2014/wait-your-cue-jazz-pharma 2/2